CONTEXTVISION AB (CONTX.OL) Fundamental Analysis & Valuation

OSL:CONTX • SE0014731154

Current stock price

3.5 NOK
0 (0%)
Last:

This CONTX.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CONTX.OL Profitability Analysis

1.1 Basic Checks

  • In the past year CONTX was profitable.
  • In the past year CONTX had a positive cash flow from operations.
  • Of the past 5 years CONTX 4 years were profitable.
  • Each year in the past 5 years CONTX had a positive operating cash flow.
CONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFCONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M 40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.61%, CONTX is doing worse than 63.64% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 0.83%, CONTX is doing worse than 63.64% of the companies in the same industry.
  • CONTX's Return On Invested Capital of 0.30% is on the low side compared to the rest of the industry. CONTX is outperformed by 63.64% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CONTX is significantly above the industry average of 7.44%.
  • The 3 year average ROIC (20.44%) for CONTX is well above the current ROIC(0.30%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.61%
ROE 0.83%
ROIC 0.3%
ROA(3y)16.48%
ROA(5y)14.4%
ROE(3y)23.03%
ROE(5y)18.42%
ROIC(3y)20.44%
ROIC(5y)37.45%
CONTX.OL Yearly ROA, ROE, ROICCONTX.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.69%, CONTX is doing worse than 63.64% of the companies in the same industry.
  • CONTX's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 0.36%, CONTX is doing worse than 63.64% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CONTX has declined.
  • With an excellent Gross Margin value of 97.37%, CONTX belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
  • CONTX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.36%
PM (TTM) 0.69%
GM 97.37%
OM growth 3Y-77.87%
OM growth 5Y-62.43%
PM growth 3Y-69.2%
PM growth 5Y-43.82%
GM growth 3Y-1.24%
GM growth 5Y-0.07%
CONTX.OL Yearly Profit, Operating, Gross MarginsCONTX.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CONTX.OL Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CONTX is creating value.
  • CONTX has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CONTX has about the same amount of shares outstanding.
  • The debt/assets ratio for CONTX is higher compared to a year ago.
CONTX.OL Yearly Shares OutstandingCONTX.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CONTX.OL Yearly Total Debt VS Total AssetsCONTX.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • CONTX has a debt to FCF ratio of 62.32. This is a negative value and a sign of low solvency as CONTX would need 62.32 years to pay back of all of its debts.
  • CONTX's Debt to FCF ratio of 62.32 is on the low side compared to the rest of the industry. CONTX is outperformed by 63.64% of its industry peers.
  • CONTX has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • CONTX has a Debt to Equity ratio (0.10) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 62.32
Altman-Z N/A
ROIC/WACC0.04
WACC7.02%
CONTX.OL Yearly LT Debt VS Equity VS FCFCONTX.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 4.28 indicates that CONTX has no problem at all paying its short term obligations.
  • CONTX has a Current ratio of 4.28. This is amongst the best in the industry. CONTX outperforms 81.82% of its industry peers.
  • CONTX has a Quick Ratio of 4.23. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of CONTX (4.23) is better than 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 4.28
Quick Ratio 4.23
CONTX.OL Yearly Current Assets VS Current LiabilitesCONTX.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CONTX.OL Growth Analysis

3.1 Past

  • The earnings per share for CONTX have decreased strongly by -96.77% in the last year.
  • CONTX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -41.36% yearly.
  • CONTX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.61%.
  • Measured over the past years, CONTX shows a small growth in Revenue. The Revenue has been growing by 3.08% on average per year.
EPS 1Y (TTM)-96.77%
EPS 3Y-69.6%
EPS 5Y-41.36%
EPS Q2Q%-42.87%
Revenue 1Y (TTM)-15.61%
Revenue growth 3Y-2.18%
Revenue growth 5Y3.08%
Sales Q2Q%-7.27%

3.2 Future

  • Based on estimates for the next years, CONTX will show a very strong growth in Earnings Per Share. The EPS will grow by 188.45% on average per year.
  • The Revenue is expected to grow by 2.70% on average over the next years.
EPS Next Y1100%
EPS Next 2Y324.26%
EPS Next 3Y188.45%
EPS Next 5YN/A
Revenue Next Year7.55%
Revenue Next 2Y4.61%
Revenue Next 3Y3.64%
Revenue Next 5Y2.7%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CONTX.OL Yearly Revenue VS EstimatesCONTX.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M
CONTX.OL Yearly EPS VS EstimatesCONTX.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. CONTX.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 350.00 indicates a quite expensive valuation of CONTX.
  • Based on the Price/Earnings ratio, CONTX is valued a bit more expensive than the industry average as 63.64% of the companies are valued more cheaply.
  • CONTX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.86.
  • CONTX is valuated quite expensively with a Price/Forward Earnings ratio of 33.12.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CONTX.
  • CONTX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 37.39, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 350
Fwd PE 33.12
CONTX.OL Price Earnings VS Forward Price EarningsCONTX.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CONTX indicates a slightly more expensive valuation: CONTX is more expensive than 72.73% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1306.75
EV/EBITDA N/A
CONTX.OL Per share dataCONTX.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1

4.3 Compensation for Growth

  • CONTX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CONTX's earnings are expected to grow with 188.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y324.26%
EPS Next 3Y188.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. CONTX.OL Dividend Analysis

5.1 Amount

  • CONTX has a Yearly Dividend Yield of 4.18%, which is a nice return.
  • CONTX's Dividend Yield is rather good when compared to the industry average which is at 2.00. CONTX pays more dividend than 90.91% of the companies in the same industry.
  • CONTX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.18%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2Y324.26%
EPS Next 3Y188.45%
CONTX.OL Yearly Income VS Free CF VS DividendCONTX.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

More info and screens

Find the best dividend stocksShow peers with best dividend

CONTX.OL Fundamentals: All Metrics, Ratios and Statistics

CONTEXTVISION AB

OSL:CONTX (4/10/2026, 7:00:00 PM)

3.5

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-19
Earnings (Next)05-08
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners23.66%
Ins Owner ChangeN/A
Market Cap270.80M
Revenue(TTM)110.28M
Net Income(TTM)762.00K
Analysts40
Price Target3.37 (-3.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.18%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-17.5%
PT rev (3m)-17.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.79%
Valuation
Industry RankSector Rank
PE 350
Fwd PE 33.12
P/S 2.39
P/FCF 1306.75
P/OCF 59.44
P/B 2.86
P/tB 2.94
EV/EBITDA N/A
EPS(TTM)0.01
EY0.29%
EPS(NY)0.11
Fwd EY3.02%
FCF(TTM)0
FCFY0.08%
OCF(TTM)0.06
OCFY1.68%
SpS1.46
BVpS1.22
TBVpS1.19
PEG (NY)0.32
PEG (5Y)N/A
Graham Number0.52
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 0.83%
ROCE 0.39%
ROIC 0.3%
ROICexc 0.96%
ROICexgc 1.03%
OM 0.36%
PM (TTM) 0.69%
GM 97.37%
FCFM 0.18%
ROA(3y)16.48%
ROA(5y)14.4%
ROE(3y)23.03%
ROE(5y)18.42%
ROIC(3y)20.44%
ROIC(5y)37.45%
ROICexc(3y)77.73%
ROICexc(5y)111.49%
ROICexgc(3y)103.93%
ROICexgc(5y)184.88%
ROCE(3y)26.61%
ROCE(5y)48.75%
ROICexgc growth 3Y-81.88%
ROICexgc growth 5Y-66.49%
ROICexc growth 3Y-79.52%
ROICexc growth 5Y-59.81%
OM growth 3Y-77.87%
OM growth 5Y-62.43%
PM growth 3Y-69.2%
PM growth 5Y-43.82%
GM growth 3Y-1.24%
GM growth 5Y-0.07%
F-Score5
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 62.32
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 3.84%
Interest Coverage 0.99
Cash Conversion N/A
Profit Quality 26.51%
Current Ratio 4.28
Quick Ratio 4.23
Altman-Z N/A
F-Score5
WACC7.02%
ROIC/WACC0.04
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)3.73%
Cap/Sales(5y)4.01%
Profit Quality(3y)87.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.77%
EPS 3Y-69.6%
EPS 5Y-41.36%
EPS Q2Q%-42.87%
EPS Next Y1100%
EPS Next 2Y324.26%
EPS Next 3Y188.45%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.61%
Revenue growth 3Y-2.18%
Revenue growth 5Y3.08%
Sales Q2Q%-7.27%
Revenue Next Year7.55%
Revenue Next 2Y4.61%
Revenue Next 3Y3.64%
Revenue Next 5Y2.7%
EBIT growth 1Y-98.68%
EBIT growth 3Y-78.36%
EBIT growth 5Y-61.27%
EBIT Next Year2775%
EBIT Next 3Y208.99%
EBIT Next 5YN/A
FCF growth 1Y-99.31%
FCF growth 3Y-78.75%
FCF growth 5Y-57.02%
OCF growth 1Y-86.52%
OCF growth 3Y-44.44%
OCF growth 5Y-27.59%

CONTEXTVISION AB / CONTX.OL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.


What is the valuation status for CONTX stock?

ChartMill assigns a valuation rating of 3 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Overvalued.


Can you provide the profitability details for CONTEXTVISION AB?

CONTEXTVISION AB (CONTX.OL) has a profitability rating of 6 / 10.


What is the valuation of CONTEXTVISION AB based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CONTEXTVISION AB (CONTX.OL) is 350 and the Price/Book (PB) ratio is 2.86.


What is the earnings growth outlook for CONTEXTVISION AB?

The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to grow by 1100% in the next year.